<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Taiwan Liposome Company, Ltd.

    Taiwan Liposome Company, Ltd.

    We are a clinical-stage specialty pharmaceutical company dedicated to the developm...

    We are a clinical-stage specialty pharmaceutica...

    Filing Type:    PU
    Cumberland Pharmaceuticals Inc.

    Cumberland Pharmaceuticals Inc.

    We are a profitable and growing company focused on the acquisition, development an...

    We are a profitable and growing company focused...

    Filing Type:    PU
    Health Catalyst, Inc

    Health Catalyst, Inc

    Health Catalyst is a leading provider of data and analytics technology and service...

    Health Catalyst is a leading provider of data a...

    Filing Type:    PU
    Akero Therapeutics, Inc.

    Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high...

    Akero aims to develop and deliver transformatio...

    Filing Type:    PU
    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc.

    DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused ...

    DiaMedica Therapeutics Inc. is a clinical stage...

    Filing Type:    PU
    Eton Pharmaceuticals, Inc.

    Eton Pharmaceuticals, Inc.

    Eton Pharmaceuticals, Inc. is a Deer Park, IL-based biopharmaceutical company focu...

    Eton Pharmaceuticals, Inc. is a Deer Park, IL-b...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    Blueprint Medicines Corporation

    Blueprint Medicines Corporation

    Blueprint Medicines is a precision therapy company striving to improve human healt...

    Blueprint Medicines is a precision therapy comp...

    Filing Type:    PU
    LifeBridge 10000, LLC

    LifeBridge 10000, LLC

    LifeBridge 10000, LLC specializes in extending and improving the quality of life f...

    LifeBridge 10000, LLC specializes in extending ...

    Amount Raised:    $23,091.00
    Fundraising Status:    EC
    Filing Type:    CF
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    Enlivex Therapeutics Ltd.

    Enlivex Therapeutics Ltd.

    Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug p...

    Enlivex is a clinical stage immunotherapy compa...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.